<h4>Background</h4>TFE3-rearranged renal cell carcinoma (TFE3-rRCC) is a rare but highly heterogeneous renal cell carcinoma (RCC) entity, of which the clinical treatment landscape is largely undefined. This evidence concerns the gene TFE3 and hereditary clear cell renal cell carcinoma.